DEFINITIVE PROXY STATEMENT

Company

Cardiff Oncology, Inc.

Filed

February 28, 2006

Period of Report

April 4, 2006

Accession Number

0001321543-06-000095

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →